| 101 | BNTXBioNTech SE |
2,9 Mrd. € |
-39,6% |
2025 |
| 102 | NBIXNeurocrine Biosciences Inc |
2,9 Mrd. $ |
16,7% |
2025 |
| 103 | ACHAccendra Health Inc |
2,8 Mrd. $ |
-39,8% |
2025 |
| 104 | QDELQuidelOrtho Corp |
2,7 Mrd. $ |
-41,5% |
2025 |
| 105 | FTREFortrea Holdings Inc. |
2,7 Mrd. $ |
-36,2% |
2025 |
| 106 | NVSTEnvista Holdings Corp |
2,7 Mrd. $ |
1,7% |
2025 |
| 107 | PODDInsulet Corp |
2,7 Mrd. $ |
9,1% |
2025 |
| 108 | MEDPMedpace Holdings, Inc. |
2,5 Mrd. $ |
17,8% |
2025 |
| 109 | CHEChemed Corp |
2,5 Mrd. $ |
10,5% |
2025 |
| 110 | TDOCTeladoc Health, Inc. |
2,5 Mrd. $ |
-7,9% |
2025 |
| 111 | AVAHAveanna Healthcare Holdings, Inc. |
2,4 Mrd. $ |
9,2% |
2026 |
| 112 | RPRXRoyalty Pharma plc |
2,4 Mrd. $ |
32,4% |
2025 |
| 113 | HIMSHims & Hers Health, Inc. |
2,3 Mrd. $ |
5,5% |
2025 |
| 114 | EXELExelixis, Inc. |
2,3 Mrd. $ |
33,7% |
2025 |
| 115 | NTRANatera, Inc. |
2,3 Mrd. $ |
-9,0% |
2025 |
| 116 | ENOVEnovis CORP |
2,2 Mrd. $ |
-52,7% |
2025 |
| 117 | ICUIIcu Medical Inc |
2,2 Mrd. $ |
0,0% |
2025 |
| 118 | SRPTSarepta Therapeutics, Inc. |
2,2 Mrd. $ |
-32,5% |
2025 |
| 119 | CONConcentra Group Holdings Parent, Inc. |
2,2 Mrd. $ |
7,7% |
2025 |
| 120 | PRVAPrivia Health Group, Inc. |
2,1 Mrd. $ |
1,1% |
2025 |
| 121 | QGENQiagen N.V. |
2,1 Mrd. $ |
20,3% |
2025 |
| 122 | RDNTRadNet, Inc. |
2 Mrd. $ |
-0,9% |
2025 |
| 123 | TFXTeleflex Inc |
2 Mrd. $ |
-45,4% |
2025 |
| 124 | EYENational Vision Holdings, Inc. |
2 Mrd. $ |
1,5% |
2025 |
| 125 | MRNAModerna, Inc. |
1,9 Mrd. $ |
-145,2% |
2025 |
| 126 | CLOVClover Health Investments, Corp. |
1,9 Mrd. $ |
-4,4% |
2025 |
| 127 | MDPediatrix Medical Group, Inc. |
1,9 Mrd. $ |
8,6% |
2025 |
| 128 | MSAMSA Safety Inc |
1,9 Mrd. $ |
14,9% |
2025 |
| 129 | ITGRInteger Holdings Corp |
1,9 Mrd. $ |
5,5% |
2025 |
| 130 | HCSGHealthcare Services Group Inc |
1,8 Mrd. $ |
3,2% |
2025 |
| 131 | PTCTPtc Therapeutics, Inc. |
1,7 Mrd. $ |
39,4% |
2025 |
| 132 | IARTIntegra Lifesciences Holdings Corp |
1,6 Mrd. $ |
-31,6% |
2025 |
| 133 | LNTHLantheus Holdings, Inc. |
1,5 Mrd. $ |
15,2% |
2025 |
| 134 | PAHCPhibro Animal Health Corp |
1,5 Mrd. $ |
6,6% |
2026 |
| 135 | NHCNational Healthcare Corp |
1,5 Mrd. $ |
7,9% |
2025 |
| 136 | MMSIMerit Medical Systems Inc |
1,5 Mrd. $ |
8,5% |
2025 |
| 137 | NUSNU Skin Enterprises, Inc. |
1,5 Mrd. $ |
10,8% |
2025 |
| 138 | ALKSAlkermes plc. |
1,5 Mrd. $ |
16,4% |
2025 |
| 139 | PIIIP3 Health Partners Inc. |
1,5 Mrd. $ |
-10,1% |
2024 |
| 140 | TRUPTrupanion, Inc. |
1,4 Mrd. $ |
1,4% |
2025 |
| 141 | LFSTLifeStance Health Group, Inc. |
1,4 Mrd. $ |
0,7% |
2025 |
| 142 | ADUSAddus HomeCare Corp |
1,4 Mrd. $ |
6,7% |
2025 |
| 143 | PENPenumbra Inc |
1,4 Mrd. $ |
12,7% |
2025 |
| 144 | HALOHalozyme Therapeutics, Inc. |
1,4 Mrd. $ |
22,7% |
2025 |
| 145 | LIVNLivaNova PLC |
1,4 Mrd. $ |
-17,5% |
2025 |
| 146 | CNMDCONMED Corp |
1,4 Mrd. $ |
3,4% |
2025 |
| 147 | HAEHaemonetics Corp |
1,3 Mrd. $ |
7,3% |
2026 |
| 148 | PGNYProgyny, Inc. |
1,3 Mrd. $ |
4,5% |
2025 |
| 149 | CURLFCuraleaf Holdings, Inc. |
1,3 Mrd. $ |
-18,2% |
2025 |
| 150 | INDVIndivior Pharmaceuticals, Inc. |
1,2 Mrd. $ |
16,9% |
2025 |